In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
about
Aging and the neurovascular unitIn vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's diseaseA review of β-amyloid neuroimaging in Alzheimer's disease.Future Directions in Imaging Neurodegeneration.Glial contributions to neurodegeneration in tauopathies.Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway.Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer's Disease?Molecular imaging of microglia/macrophages in the brain.Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models.Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's diseaseIsoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease.Neurodegeneration severity can be predicted from early microglia alterations monitored in vivo in a mouse model of chronic glaucoma.Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.In vivo dynamics of retinal microglial activation during neurodegeneration: confocal ophthalmoscopic imaging and cell morphometry in mouse glaucomaEvaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation.Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice.SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.A phenotypic change but not proliferation underlies glial responses in Alzheimer diseasePET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamide.PET imaging of inflammation biomarkers.Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET.Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controlsLongitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors.Noninvasive quantification of metabotropic glutamate receptor type 1 with [¹¹C]ITDM: a small-animal PET study.The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update.Molecular imaging of dementia.Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.Modulation of inflammation in transgenic models of Alzheimer's diseaseThe translocator protein as a drug target in Alzheimer's disease.Imaging of cerebrovascular pathology in animal models of Alzheimer's disease[18F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's Disease.Radiosynthesis and in vivo Evaluation of Carbon-11 (2S)-3-(1H-Indol-3-yl)-2-{[(4-methoxyphenyl)carbamoyl]amino}-N-{[1-(5-methoxypyridin-2-yl)cyclohexyl]methyl}propanamide: An Attempt to Visualize Brain Formyl Peptide Receptors in Mouse Models of NeuNeuroinflammation in Neurodegenerative Disorders-a Review.Microglia function in Alzheimer's disease.Alzheimer's disease biomarkers in animal models: closing the translational gap.In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.Distinct binding of amyloid imaging ligands to unique amyloid-β deposited in the presubiculum of Alzheimer's disease.In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA.
P2860
Q27026843-2778E4DD-C1B5-4F89-BF80-B8D110337186Q28274003-1C753211-4B16-47ED-BFAE-F6EBC5D5ED65Q30870063-D6D73F3C-8A1A-4706-BD75-F3935D19F5E3Q31162702-B54CF36E-DCCD-4163-AD2A-0B5F9EBFBD5EQ32173558-2B6745C4-E605-4510-B564-F0F6F5F91B80Q33726281-9AF48EAF-9738-49DB-9350-A0599517FE4FQ33904501-FAC99908-98C9-44A4-8052-F464203180A2Q34063312-D7F76248-6F23-4268-8317-079E05D3C138Q34276818-33A7D982-A10D-4CBE-A090-43C68FA35EACQ35112618-9CF8B6B6-0922-4A2F-85DB-153A21E38EEEQ35167904-8BE43DEA-A040-416B-B0FC-9607A2BEF2FCQ35197124-04063B8E-0FBB-4FEE-B89C-86CCD9D6F8F9Q35558052-CF4695B9-ECCD-4244-B718-A1767488BD2BQ35582909-DDCAC626-03D7-4023-8DA2-3C3DD2F5E567Q35974720-037D25AD-85E8-4FB2-8E73-4A6110921B0FQ36488310-A1CC69F6-5235-40F6-97E0-3B36E75C1AABQ36693341-2FF28ACA-0524-4BC1-B4D4-723D99BC22B7Q36710294-D4936E7A-A058-48F2-91E1-D82CBA8449D3Q36766806-CDA905EF-2E1D-4CBC-9063-08670616C0E2Q36888341-C0775DE2-854B-4E69-9B7B-6AF6AE379B10Q36900751-EE85574D-76FF-47BF-9F30-735EDE8F6E08Q36997603-E2546471-0E3E-4CE8-B31D-027018BE3380Q37220627-DB18B3F1-1302-492D-AEEE-136F4A189E90Q37259426-34DA9EF3-29CA-4FF6-9F10-A08C7EA7EC7FQ37663675-E3983DD7-FEB3-4FB4-8595-50888B800F34Q37695328-C4846DDF-84C4-4345-ACAB-D01CADBBCC6CQ37998086-52A45BCC-7A29-4096-A821-7099C917E92DQ38019956-F4BBCFB0-250B-4FBC-B136-6C6AF55CD6CBQ38170338-C98E47D8-EAD9-4833-8645-39EAA07F10ADQ38184606-97B80D90-C1F7-4537-8B32-8F3AA17DBB7AQ38195637-D26EEF98-06F7-42F4-B94F-9A0EF53705D2Q38198632-8834323A-AAA8-47A8-B263-7D910FD2CEDDQ38772065-39D1030E-E250-4099-B911-1B885C9325CAQ38859451-42937C24-2F69-42C5-9D9A-684D7B68173BQ39173756-4B4C2745-CD7A-4152-8943-EA3218FA0FACQ41014561-034A8D9B-F07B-4FC4-8D9F-5D03D8DE7BE3Q41822193-6DECC661-1956-42CE-AC30-C32A3489F39CQ47865475-AA86C73E-E153-4908-BCB4-2C8005A8C93BQ48140837-A1A60863-A53C-4EE8-97A0-75A02B33CA1DQ48314517-A6E5B1ED-6035-4DD1-B10D-44B487CD8146
P2860
In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vivo positron emission tomo ...... disease and related disorders.
@ast
In vivo positron emission tomo ...... disease and related disorders.
@en
type
label
In vivo positron emission tomo ...... disease and related disorders.
@ast
In vivo positron emission tomo ...... disease and related disorders.
@en
prefLabel
In vivo positron emission tomo ...... disease and related disorders.
@ast
In vivo positron emission tomo ...... disease and related disorders.
@en
P2093
P2860
P1476
In vivo positron emission tomo ...... disease and related disorders.
@en
P2093
Hiroshi Mori
Katsushi Kumata
Makoto Higuchi
Ming-Rong Zhang
Nobuhisa Iwata
Satoko Hattori
Takami Tomiyama
P2860
P304
P356
10.1523/JNEUROSCI.3076-10.2011
P407
P577
2011-03-01T00:00:00Z